- Human Biospecimens
- For Researchers
- For Biospecimen Contributors
- For Patients
July 2, 2019
What makes one person able to take painkillers without incident while another becomes addicted, and a third overdoses and dies? New Jersey researchers are exploring these questions, using a first-of-its-kind biobank of brains and blood samples from opioid users. In a three-year, $4 million study, researchers and clinicians from the Coriell Institute for Medical […]
Emily is director of site management and development at iSpecimen, where she develops relationships with organizations that want to share human biospecimens with researchers on the iSpecimen Marketplace. 1. Where do the human biofluids, tissues and cells available on the iSpecimen Marketplace come from? The specimens and data available on the iSpecimen Marketplace come from […]
June 13, 2019
Although biobanks around the world have since amassed millions of human biospecimens, and valuable insights have been extracted from them, the biospecimen procurement challenge is holding firm. Recently, iSpecimen launched a survey of its own, recasting several questions similar to those included in the aforementioned OBBR survey, to take a pulse on potential improvements related to the availability of quality specimens.
May 30, 2019
Researchers in Shanghai reviewed 21 studies that looked at more than 1,500 people and found that more than half of those studies “showed that regulating intestinal flora can effectively improve anxiety symptoms.”
May 23, 2019
A protein that has commonly helped doctors diagnose a heart attack could also be used to help predict heart problems years in advance. New research from Baylor University indicates that adding troponin I to a commonly used risk prediction model led to more accurate risk prediction for heart attack, stroke and heart failure hospitalization.
May 16, 2019
One of the hardest things about chronic fatigue syndrome is the stigma—the notion that it just might be all in your head. Chronic fatigue syndrome afflicts an estimated 800,000 to 2 million Americans and has no known cure. Symptoms include malaise, sleep problems, pain, dizziness and difficulty concentrating. The diagnosis, when made at all, is typically withheld until other diseases are ruled out.
May 9, 2019
Finding the right clinical trials for very sick patients may be getting more precise and timely.Rather than enrolling patients in a trial based on their cancer type or a biopsy conducted months or years earlier, researchers in the UK recently used blood tests to get an up-to-date profile of genetic faults in the blood of 100 patients. In 11 cases, the researchers used the data to enroll them into an available “molecularly matched” clinical trial.
May 2, 2019
We dove deep into the biospecimen procurement challenge in our first webinar, “From Chaos to Control: Transforming Biospecimen Procurement,” which we conducted last Wednesday but have recorded for you here.
April 26, 2019
Researchers analyze a lot of data about specific diseases to discover new biomarkers and better predict treatment outcomes.University of Nottingham UK researchers, however, have taken a wide-angle approach to data and disease, enabling computers to essentially teach themselves to better predict early death from chronic disease in a large middle-aged population.